> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-38/
- Published: 2021-05-09T12:00:00.000Z
- Updated: 2026-09-14T16:58:06.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5149284

**OMB Approves 6 FDA Information Collections**  
5/7/2021*Federal Register* notice: FDA has announced the following information collections have been approved by OMB:

- Applications for FDA Approval to Market a New Drug (0910-0001)
- Medical Devices; Humanitarian Use Devices (0910-0332)
- Medical Devices; Device Tracking (0910-0442)
- Dispute Resolution Procedures for Science Based Decision on Products Regulated by CVM (0910-0566)
- Use of Public Human Genetic Variant Databases to Support Clinical Validity for Genetic and Genomic-Based In Vitro Diagnostics (0910-0850)
- Assessment of Terms and Phrases Commonly Used in Prescription Drug Promotion (0910-0895)

To view the notice, click [here](https://public-inspection.federalregister.gov/2021-09811.pdf?ref=fdaweb.com).

**Info Collection on Medical Product Communications**  
5/7/2021 *Federal Register* notice: FDA is seeking comments on an information collection extension entitled “Medical Product Communications That Are Consistent With the FDA-Required Labeling — Questions and Answers” (OMB Control Number 0910-0856). The collection supports FDA regulations that govern drug and device labeling and prescription drug and restricted device advertising. To view the notice, click [here](https://public-inspection.federalregister.gov/2021-09809.pdf?ref=fdaweb.com).

**Condom Labeling Information Collection**  
5/7/2021 *Federal Register* notice: FDA has submitted to OMB and information collection extension entitled “Class 2 Special Controls Guidance Document: Labeling for Natural Rubber Latex Condoms — 21 CFR 884.5300.” To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2021-05-07/pdf/2021-09620.pdf?ref=fdaweb.com).

**Info Collection on Device Classification Inquiries**  
5/6/2021 *Federal Register* notice: FDA has submitted to OMB an information collection extension entitled “513(g) Request for Information” (OMB Control Number 0910-0705). The collection supports FDA regulations and guidance related to obtaining the agency’s views about the classification and regulatory requirements that may be applicable to a particular device. To view the notice, click [here](https://public-inspection.federalregister.gov/2021-09624.pdf?ref=fdaweb.com).

**Pharmacy Compounding Advisory Panel Meets 6/9**  
5/6/2021 *Federal Register* notice: FDA has announced a 6/9 Pharmacy Compounding Advisory Committee meeting. Panel members are scheduled to discuss four bulk drug substances nominated for inclusion on the 503A Bulks List — choline chloride, oxitriptan (also known as 5-hydroxytryptophan or 5-HTP), melatonin, and methylcobalamin. To view the notice, click [here](https://public-inspection.federalregister.gov/2021-09621.pdf?ref=fdaweb.com).